Cargando…
Inhibition of citrate cotransporter Slc13a5/mINDY by RNAi improves hepatic insulin sensitivity and prevents diet-induced non-alcoholic fatty liver disease in mice
OBJECTIVE: Non-alcoholic fatty liver disease is a world-wide health concern and risk factor for cardio-metabolic diseases. Citrate uptake modifies intracellular hepatic energy metabolism and is controlled by the conserved sodium-dicarboxylate cotransporter solute carrier family 13 member 5 (SLC13A5,...
Autores principales: | Brachs, Sebastian, Winkel, Angelika F., Tang, Hui, Birkenfeld, Andreas L., Brunner, Bodo, Jahn-Hofmann, Kerstin, Margerie, Daniel, Ruetten, Hartmut, Schmoll, Dieter, Spranger, Joachim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5081411/ https://www.ncbi.nlm.nih.gov/pubmed/27818933 http://dx.doi.org/10.1016/j.molmet.2016.08.004 |
Ejemplares similares
-
Chronic Activation of Hepatic Nrf2 Has No Major Effect on Fatty Acid and Glucose Metabolism in Adult Mice
por: Brachs, Sebastian, et al.
Publicado: (2016) -
Correction: Chronic Activation of Hepatic Nrf2 Has No Major Effect on Fatty Acid and Glucose Metabolism in Adult Mice
por: Brachs, Sebastian, et al.
Publicado: (2017) -
The longevity transporter mIndy (Slc13a5) as a target for treating hepatic steatosis and insulin resistance
por: Willmes, Diana M., et al.
Publicado: (2016) -
Functional analysis of a species-specific inhibitor selective for human Na(+)-coupled citrate transporter (NaCT/SLC13A5/mINDY)
por: Higuchi, Kei, et al.
Publicado: (2020) -
Prevention of diet-induced hepatic steatosis and hepatic insulin resistance by second generation antisense oligonucleotides targeted to the longevity gene mIndy (Slc13a5)
por: Pesta, Dominik H., et al.
Publicado: (2015)